<?xml version='1.0' encoding='utf-8'?>
<document id="10405388"><sentence text="Piperacillin enhances the inhibitory effect of tazobactam on β-lactamase through inhibition of organic anion transporter 1/3 in rats."><entity charOffset="0-12" text="Piperacillin" /><entity charOffset="47-57" text="tazobactam" /></sentence><sentence text="To assess the mechanism of the pharmacokinetic interaction between piperacillin and tazobactam, renal excretion and pharmacokinetic studies of piperacillin/tazobactam were investigated in normal and bacteremia rats"><entity charOffset="67-79" text="piperacillin" /><entity charOffset="84-94" text="tazobactam" /><entity charOffset="143-155" text="piperacillin" /><entity charOffset="156-166" text="tazobactam" /></sentence><sentence text=" A bacteremia model was established to investigate the pharmacokinetic properties of piperacillin and tazobactam under different conditions"><entity charOffset="85-97" text="piperacillin" /><entity charOffset="102-112" text="tazobactam" /></sentence><sentence text=" Renal slices were taken to examine the uptake of piperacillin and tazobactam"><entity charOffset="50-62" text="piperacillin" /><entity charOffset="67-77" text="tazobactam" /></sentence><sentence text=" Pharmacokinetic studies of β-lactamase in rats were performed to study the contribution of rOat1/3 to the inhibition of tazobactam on β-lactamase"><entity charOffset="121-131" text="tazobactam" /></sentence><sentence text=" The AUC (from 2" /><sentence text="93 ± 0" /><sentence text="58 to 6" /><sentence text="52 ± 1" /><sentence text="44 mg·min/ml) and the plasma clearance (CLP ) (from 2" /><sentence text="41 ± 1" /><sentence text="20 to 0" /><sentence text="961 ± 0" /><sentence text="212 ml/min/kg) of tazobactam were both altered after the intravenous coadministration of piperacillin and tazobactam in the bacteremia rats"><entity charOffset="18-28" text="tazobactam" /><entity charOffset="89-101" text="piperacillin" /><entity charOffset="106-116" text="tazobactam" /></sentence><sentence text=" The renal clearance (CLR ) of tazobactam decreased from 1"><entity charOffset="31-41" text="tazobactam" /></sentence><sentence text="30 ± 0" /><sentence text="50 to 0" /><sentence text="361 ± 0" /><sentence text="043 ml/min/kg" /><sentence text=" In summary, there was a beneficial interaction between piperacillin and tazobactam mediated by rOat1 and rOat3"><entity charOffset="56-68" text="piperacillin" /><entity charOffset="73-83" text="tazobactam" /></sentence><sentence text=" Piperacillin enhances the inhibitory effect of tazobactam on β-lactamase through the inhibition of rOat1 and rOat3 in rats"><entity charOffset="1-13" text="Piperacillin" /><entity charOffset="48-58" text="tazobactam" /></sentence><sentence text=" The contribution rate of rOat1/3 for the synergistic effect was 20% when the two drugs were coadministered" /><sentence text="" /></document>